Induction Chemo-Radiotherapy and Maintenance Alternating Chemotherapy for Small Cell Lung Cancer

References

• Bergsagel D, Feld R. Small cell lung cancer is still a problem. J Clin Oncol 1984; 2: 1189–91
   PubMed Web of Science ®Google Scholar
• Smyth J F, Hansen H H. Current status on research into small cell carcinoma of the lung: Summary of the Second Workshop of the International Association for the Study of Lung Cancer (IASLC). Eur J Cancer Clin Oncol 1985; 21: 1295–8
   PubMedGoogle Scholar
• Ihde D C. Current status of therapy for small cell carcinoma of the lung. Cancer 1984; 54: 2722–8
   PubMedGoogle Scholar
• Morstyn G, Ihde D C, Lichter A S. Small cell cancer 1973–1983: Early progress and recent obstacles. Int J Radiat Oncol Biol Phys 1984; 10: 515–49
   PubMed Web of Science ®Google Scholar
• Aisner J, Alberto P, Bitran J, et al. Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer Workshop. Cancer Treat Rep 1983; 67: 37–43
   PubMedGoogle Scholar
• Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 1973; 4: 31–42
   Google Scholar
• Miller A B, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–14
   PubMed Web of Science ®Google Scholar
• Peto R, Pike M C, Armitage P, Breslow N E, Cox D R, Howard S U. Design and analysis of randomized clinical trials requiring prolonged observations of each patients. II. Analysis and example. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Seifter E J, Ihde D C. Therapy of small cell lung cancer: a perspective on two decades of clinical research. Semin Oncol 1988; 3: 278–99
   Google Scholar
• Jacobs R H, Greenburg A, Bitran J D, et al. A 10-year experience with combined modality therapy for stage III small cell lung carcinoma. Cancer 1986; 58: 2177–84
   PubMed Web of Science ®Google Scholar
• Abelof M D, Ettinger D S, Order S E, Khouri N, Mellits E D, Dorschel N T. Intensive induction chemotherapy for small cell carcinoma of the lung. Cancer Treat Rep 1981; 65: 639–46
   PubMedGoogle Scholar
• Choen M H, Ihde D C, Bunn P A, Jr, et al. Cyclic alternating combination therapy for small cell bronchogenic carcinoma. Cancer Treat Rep 1979; 63: 163–70
   PubMedGoogle Scholar
• Evans W K, Shepherd F A, Feld R. VP-16 and cisplatin as first-line therapy for small cell lung cancer. J Clin Oncol 1985; 3: 1471–7
   PubMed Web of Science ®Google Scholar
• Murray N, Sha H A, Brown E, Kostashuk E, Laukkanen E, Goldie J. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small cell carcinoma of the lung. Semin Oncol 1986, Suppl 3: 24–30
   PubMedGoogle Scholar
• Daniels J R, Chak L Y, Sikic B I, Lockbaum P, Kohler M, Carter S K. Chemotherapy of small cell carcinoma of lung: A randomized comparison of alternating and sequential combination chemotherapy programs. J Clin Oncol 1984; 2: 1192–9
   PubMed Web of Science ®Google Scholar
• Natale R B, Shan K B, Hilaris B S. Combination cyclophosphamide, adriamicin and VP-16 in treatment of small cell lung cancer. Am J Med 1985; 79: 303–8
   PubMed Web of Science ®Google Scholar
• Hande K R, Des Prez R M. Current perspectives in small cell lung cancer. Chest 1984; 85: 669–77
   PubMed Web of Science ®Google Scholar
• Livingston R B, Mira J G, Chew T T, Mc Gravan M, Costanzi J J, Samson M. Combined modality treatment of extensive small cell lung cancer: A Southwest Oncology Group Study. J Clin Oncol 1984; 2: 585–90
   PubMedGoogle Scholar
• Evans W K, Feld R, Murray N, Willan A, Coy P, Osoba D. Superiority of alternating non-cross resistant chemotherapy in extensive small cell lung cancer. Ann Int Med 1987; 107: 451–8
   PubMed Web of Science ®Google Scholar
• Johnson B E, Nau M M, Gadzar A F. Oncogene amplification of c-myc and n-myc in cell lines established from patients with small cell lung cancer is associated with shortened survival. Proc Am Soc Clin Oncol 1985; 4: 186
   Google Scholar
• Little C D, Nau M M, Carney D N, Gadzar A F, Minna J D. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 1983; 306: 194–6
   PubMed Web of Science ®Google Scholar
• Beck L K, Kane M A, Bunn P A, Jr. Innovative and future approaches to small cell lung cancer treatment. Semin Oncol 1988; 3: 300–14
   Google Scholar